South African researchers hope to restart J&J vaccination next week

PUBLISHED: Wed, 21 Apr 2021 17:01:12 GMT

JOHANNESBURG, April 21 (Reuters) – South African researchers hope to restart use of Johnson & Johnson’s COVID-19 vaccine next week in an “implementation study” immunising healthcare workers, a top local scientist said on Wednesday.

South Africa suspended the study last week after U.S. federal health agencies recommended pausing use of J&J’s vaccine because of rare cases of blood clots.

“We do hope to start again next week,” South African Medical Research Council President Glenda Gray said during a webinar.

(Reporting by Alexander Winning and Wendell Roelf; editing by Mfuneko Toyana)

(c) Copyright Thomson Reuters 2021. Click For Restrictions –

Sign Up for Our Newsletter Daily Update
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.